Organisation paid for research Program year 2023 Source: CMS Open Payments

Washington Univ Infusion Ctr Pharm

Neither a doctor nor a teaching hospital

Research payments

$1,272,125

5 payments

Through program year 2023, Washington Univ Infusion Ctr Pharm is reported as receiving $1,272,125 in research payments, across 5 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$9,448	1
2020	Research	$66,186	1
2019	Research	$1,196,490	3

Breakdown

Who paid Research payments · program years 2019–2023

Amgen Inc. $1,272,125 5 payments

Studies the money was for Research payments · program years 2019–2023

A pilot Trial of Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients with DLBCL $698,683 2 payments
AMG 510_P1/2 Monotherapy NSCLC/CRC/Tumor Agnostic_20170543. $563,514 1 payment
A Phase 1 FIH PRMT5i therapy for treatment of MTAP null NSCLS $9,448 1 payment
AMG 397_Combo in multiple hematologic indications_20170173 $480 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.